Skip to main content

Table 2 Prevalence of EGF genotypes and allele frequencies among melanoma and non-melanoma subjects.

From: Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls

Genotype Healthy controls
(%)
Melanoma patients
(%)
Odds ratio*
(95% CI)
A/A 93
(36.5%)
144
(34.4%)
1.00
A/G 117
(45.9%)
206
(49.3%)
1.13
(0.57–2.11)
G/G 45
(17.6%)
68
(16.3%)
0.89
(0.29–1.63)
Total cases 255 418  
Allele    
A 303
(60%)
494
(59%)
1.00
G 207
(40%)
342
(41%)
1.04
(0.39–1.97)
  1. *adjusted for age and sex. CI, confidence interval